These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19623715)

  • 21. Short-course therapy of gemifloxacin effective against pneumococcal pneumonia in mice.
    Bast DJ; Dresser L; Duncan CL; Walker SE; Mandell LA; Low DE; de Azavedo JC
    J Chemother; 2006 Dec; 18(6):634-40. PubMed ID: 17267342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoroquinolone resistance in Streptococcus pneumoniae: area under the concentration-time curve/MIC ratio and resistance development with gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacin.
    LaPlante KL; Rybak MJ; Tsuji B; Lodise TP; Kaatz GW
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1315-20. PubMed ID: 17296740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro pharmacodynamic activity of gatifloxacin, gemifloxacin, moxifloxacin and levofloxacin against Streptococcus pneumoniae containing specific mutations in DNA gyrase and topoisomerase IV.
    Garrison MW; Schimmels JA; Madaras-Kelly KJ
    Diagn Microbiol Infect Dis; 2003 Dec; 47(4):587-93. PubMed ID: 14711480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniae.
    Lister PD; Sanders CC
    J Antimicrob Chemother; 2001 Jun; 47(6):811-8. PubMed ID: 11389113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of gemifloxacin for the treatment of experimental Staphylococcus aureus keratitis.
    Wu X; Jiang H; Xu Y; Yue W; Yang L; Song Z; Chen H; Liu T
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):420-7. PubMed ID: 22360669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent tendinitis after treatment with two different fluoroquinolones.
    Burkhardt O; Köhnlein T; Pap T; Welte T
    Scand J Infect Dis; 2004; 36(4):315-6. PubMed ID: 15198194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
    Kosowska-Shick K; Credito K; Pankuch GA; Lin G; Bozdogan B; McGhee P; Dewasse B; Choi DR; Ryu JM; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2064-71. PubMed ID: 16723567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
    Kowalski RP; Dhaliwal DK; Karenchak LM; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2003 Sep; 136(3):500-5. PubMed ID: 12967804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel method of estimating cost of therapy by using patient population characteristics: analysis of fluoroquinolones in various populations with different distributions of renal function.
    Enzweiler KA; Bosso JA; White RL
    Pharmacotherapy; 2003 Jul; 23(7):925-32. PubMed ID: 12885105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moxifloxacin prophylaxis in neutropenic patients.
    von Baum H; Sigge A; Bommer M; Kern WV; Marre R; Döhner H; Kern P; Reuter S
    J Antimicrob Chemother; 2006 Oct; 58(4):891-4. PubMed ID: 16880172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders.
    Russell P; Eley SM; Ellis J; Green M; Bell DL; Kenny DJ; Titball RW
    J Antimicrob Chemother; 2000 Jun; 45(6):813-8. PubMed ID: 10837435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular accumulation of fluoroquinolones is not predictive of their intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a pharmacokinetic/pharmacodynamic model of uninfected and infected macrophages.
    Vallet CM; Marquez B; Ngabirano E; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    Int J Antimicrob Agents; 2011 Sep; 38(3):249-56. PubMed ID: 21764262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae.
    Nagai K; Davies TA; Dewasse BE; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 2001 Sep; 48(3):365-74. PubMed ID: 11533001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experimental study on chemotherapy of acute glanders].
    Iliukhin VI; Rotov KA; Senina TV; Snatenkov EA; Tikhonov SN; Plekhanova NG; Kulikova AS; Shubnikova EV; Korol' EV; Nekhezina MO
    Antibiot Khimioter; 2012; 57(11-12):11-5. PubMed ID: 23700931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of gatifloxacin, moxifloxacin and ciprofloxacin for treatment of experimental Burkholderia pseudomallei infection.
    Steward J; Piercy T; Lever MS; Nelson M; Simpson AJ; Brooks TJ
    J Antimicrob Chemother; 2005 Apr; 55(4):523-7. PubMed ID: 15731198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human aqueous humor levels of oral ciprofloxacin, levofloxacin, and moxifloxacin.
    García-Sáenz MC; Arias-Puente A; Fresnadillo-Martinez MJ; Carrasco-Font C
    J Cataract Refract Surg; 2001 Dec; 27(12):1969-74. PubMed ID: 11738912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gatifloxacin, gemifloxacin, and moxifloxacin: the role of 3 newer fluoroquinolones.
    Saravolatz LD; Leggett J
    Clin Infect Dis; 2003 Nov; 37(9):1210-5. PubMed ID: 14557966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of three fluoroquinolones on QT interval in healthy adults after single doses.
    Noel GJ; Natarajan J; Chien S; Hunt TL; Goodman DB; Abels R
    Clin Pharmacol Ther; 2003 Apr; 73(4):292-303. PubMed ID: 12709719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis.
    Thibodeaux BA; Dajcs JJ; Caballero AR; Marquart ME; Girgis DO; O'Callaghan RJ
    Curr Eye Res; 2004 May; 28(5):337-42. PubMed ID: 15287370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of postexposure therapy against glanders in mice.
    Waag DM
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2236-41. PubMed ID: 25645854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.